Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators
申请人:Dana-Farber Cancer Institute, Inc.
公开号:US11136409B2
公开(公告)日:2021-10-05
The present invention is based, in part, on the identification of novel USP10 biomarkers and modulators, and methods of use thereof, for identifying, assessing, preventing, and treating AML.
COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF AML USING USP10 BIOMARKERS AND MODULATORS
申请人:BUHRLAGE Sara
公开号:US20190202929A1
公开(公告)日:2019-07-04
The present invention is based, in part, on the identification of novel USP10 biomarkers and modulators, and methods of use thereof, for identifying, assessing, preventing, and treating AML.
[EN] COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF AML USING USP10 BIOMARKERS AND MODULATORS<br/>[FR] COMPOSITIONS ET MÉTHODES POUR L'IDENTIFICATION, L'ÉVALUATION, LA PRÉVENTION ET LE TRAITEMENT DE LA LMA AU MOYEN DE BIOMARQUEURS USP10 ET DE MODULATEURS
申请人:DANA FARBER CANCER INST INC
公开号:WO2018057618A1
公开(公告)日:2018-03-29
The present invention is based, in part, on the identification of novel USP10 biomarkers and modulators, and methods of use thereof, for identifying, assessing, preventing, and treating AML.